Survivor (n = 19) | Non-survivor (n = 11) | p value | |
---|---|---|---|
Age (years, mean ± SD) | 58.1 ± 16.9 | 66.1 ± 16.2 | 0.215 |
Gender (% of male) | 57.9 | 54.5 | – |
SAPS II (mean ± SD) | 51.65 ± 19.23 | 73.69 ± 13.85 | 0.002* |
SOFA (mean ± SD) | 8.18 ± 3.52 | 12.29 ± 1.43 | <0.001** |
PT (s) (median, IQR) | 13.96 (13.11–15.13) | 14.48 (13.64–1.69) | 0.127 |
aPTT (s) (mean ± SD) | 55.18 ± 10.32 | 70.46 ± 22.92 | 0.020* |
Platelet count (×10) (mean ± SD) | 209.3 ± 83.1 | 148.9 ± 72.9 | 0.055 |
White blood cell count (mean ± SD) | 14.08 ± 8.61 | 17.63 ± 9.04 | 0.293 |
CRP (mean ± SD) | 231.35 ± 99.73 | 226.79 ± 106.89 | 0.928 |
HK (mean ± SD) | 0.284 ± 0.032 | 0.282 ± .021 | 0.832 |
Hb (mean ± SD) | 5.75 ± 0.65 | 5.74 ± 0.48 | 0.952 |
Procalcitonin (median, IQR) | 2.40 (1.36–14.93) | 2.73 (1.12–7.99) | 0.846 |
MVs, phosphatidylserine (nM) (mean ± SD) | 18.69 ± 6.13 | 16.63 ± 6.33 | 0.388 |
TF (pg/ml) (mean ± SD) | 269.75 ± 171.47 | 325.22 ± 169.82 | 0.399 |